Compare Stocks → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:DOCOTCMKTS:KREVFNYSE:MFANYSE:OFCNYSE:PGRE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCHealthpeak Properties$17.97-0.2%$15.84$15.24▼$22.38$12.75B1.027.34 million shs5.39 million shsKREVFKeppel REIT$0.58-7.1%$0.64$0.55▼$0.74$2.16B0.5928,449 shs120 shsMFAMFA Financial$10.43+1.5%$11.04$8.41▼$11.90$1.06B2.1766,939 shs528,836 shsOFCCorporate Office Properties Trust$25.52$21.59▼$28.69$2.81B1.03733,029 shs542,700 shsPGREParamount Group$4.57+2.7%$4.60$4.06▼$5.92$993.20M1.221.32 million shs921,014 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCHealthpeak Properties-0.33%-3.59%+2.97%+37.90%+23.44%KREVFKeppel REIT0.00%0.00%-4.31%-12.02%-5.80%MFAMFA Financial+0.29%-5.17%-9.39%-10.45%+1.88%OFCCorporate Office Properties Trust0.00%0.00%0.00%0.00%+7.18%PGREParamount Group-0.67%-5.52%-3.47%-10.64%-2.63%Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOCHealthpeak Properties3.6311 of 5 stars1.23.02.53.72.81.71.9KREVFKeppel REITN/AN/AN/AN/AN/AN/AN/AN/AMFAMFA Financial3.0484 of 5 stars2.33.01.70.02.91.72.5OFCCorporate Office Properties Trust3.1228 of 5 stars3.20.03.31.90.60.03.1PGREParamount Group2.7557 of 5 stars0.92.01.72.12.62.51.9Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCHealthpeak Properties2.44Hold$17.67-1.69% DownsideKREVFKeppel REIT2.00HoldN/AN/AMFAMFA Financial2.67Moderate Buy$12.0015.05% UpsideOFCCorporate Office Properties Trust2.33Hold$29.00∞ UpsidePGREParamount Group1.80Reduce$4.600.66% UpsideCurrent Analyst RatingsLatest PGRE, DOC, MFA, OFC, and KREVF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/18/2024MFAMFA FinancialJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$12.504/10/2024DOCHealthpeak PropertiesRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$21.00 ➝ $22.004/1/2024DOCHealthpeak PropertiesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Buy$18.00 ➝ $25.003/28/2024PGREParamount GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$4.70 ➝ $4.503/25/2024DOCHealthpeak PropertiesWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$19.003/18/2024PGREParamount GroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ In-Line$5.003/8/2024DOCHealthpeak PropertiesRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$21.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCHealthpeak Properties$543.46M23.46$1.74 per share10.33$12.57 per share1.43KREVFKeppel REIT$173.57M12.42$0.07 per share7.89$1.14 per share0.51MFAMFA Financial$605.60M1.76$1.65 per share6.33$18.64 per share0.56OFCCorporate Office Properties Trust$739.03M0.00N/A9.61$15.31 per share0.00PGREParamount Group$742.79M1.34N/AN/A$18.47 per share0.25Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCHealthpeak Properties$306.01M$0.5632.099.611.7813.97%4.34%1.95%4/25/2024 (Confirmed)KREVFKeppel REIT$125.54MN/A0.00∞N/AN/AN/AN/AN/AMFAMFA Financial$80.16M$0.4026.086.95N/A13.24%9.44%1.82%5/6/2024 (Confirmed)OFCCorporate Office Properties Trust$173.03M$1.6914.760.000.9427.43%10.93%4.49%N/APGREParamount Group-$259.74M-$1.20N/A7.370.24-34.97%-6.07%-3.13%5/1/2024 (Confirmed)Latest PGRE, DOC, MFA, OFC, and KREVF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2024N/AMFAMFA Financial$0.36N/A-$0.36N/AN/AN/A 5/1/2024N/APGREParamount Group$0.20N/A-$0.20N/AN/AN/A 4/25/2024N/ADOCHealthpeak Properties$0.44N/A-$0.44N/AN/AN/A 2/22/2024Q4 2023MFAMFA Financial$0.34$0.46+$0.12$0.12$43.75 million$169.88 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCHealthpeak Properties$1.206.68%N/A214.29%N/AKREVFKeppel REITN/AN/AN/AN/AN/AMFAMFA Financial$1.4013.42%+2.50%350.00%N/AOFCCorporate Office Properties Trust$1.14N/AN/A67.46%1 YearsPGREParamount Group$0.143.06%-16.23%N/A N/ALatest PGRE, DOC, MFA, OFC, and KREVF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/7/2024MFAMFA FinancialQuarterly$0.3512.52%3/27/20243/28/20244/30/20243/15/2024PGREParamount GroupQuarterly$0.03503.04%3/27/20243/28/20244/15/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCHealthpeak Properties1.000.670.67KREVFKeppel REITN/AN/AN/AMFAMFA Financial4.49N/AN/AOFCCorporate Office Properties Trust1.222.102.10PGREParamount Group0.954.614.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCHealthpeak Properties93.57%KREVFKeppel REITN/AMFAMFA Financial65.28%OFCCorporate Office Properties TrustN/APGREParamount Group65.64%Insider OwnershipCompanyInsider OwnershipDOCHealthpeak Properties0.30%KREVFKeppel REITN/AMFAMFA Financial0.67%OFCCorporate Office Properties Trust0.87%PGREParamount Group13.50%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDOCHealthpeak Properties193709.58 million707.45 millionOptionableKREVFKeppel REIT233.72 billionN/ANot OptionableMFAMFA Financial377102.08 million101.40 millionOptionableOFCCorporate Office Properties Trust395112.54 million111.56 millionOptionablePGREParamount Group329217.33 million187.99 millionOptionablePGRE, DOC, MFA, OFC, and KREVF HeadlinesSourceHeadlineAre Investors Undervaluing Paramount Group (PGRE) Right Now?zacks.com - April 15 at 10:46 AMReddit Group With 1 Million Paramount Shares Are 'Deeply Disturbed' by Potential Skydance Dealmsn.com - April 12 at 4:24 PMPGRE or EGP: Which Is the Better Value Stock Right Now?zacks.com - April 12 at 12:41 PMParamount Group, Inc. (NYSE:PGRE) Given Average Recommendation of "Reduce" by Brokeragesamericanbankingnews.com - April 12 at 4:16 AMParamount Announces Release Date for First Quarter 2024 Resultsbusinesswire.com - April 11 at 4:15 PMMidtown office landlord Paramount Group doubles CEO’s paycrainsnewyork.com - April 8 at 4:15 PMParamount, Skydance Deal Talks Fuel Investor Interest But Charts Indicate Mixed Sentimentsbenzinga.com - April 3 at 9:32 AMNetflix Co-Founder Says The Best Reason To Work On A Startup 'Isn't To Make Money'msn.com - April 1 at 12:19 PMI'm subscribing to Paramount Plus in April — here's whymsn.com - April 1 at 7:15 AMShould Value Investors Buy Paramount Group (PGRE) Stock?zacks.com - March 29 at 10:47 AMNew on Paramount Plus in April 2024 — all the new shows and movies to watchmsn.com - March 29 at 8:15 AMParamount Group (NYSE:PGRE) Price Target Lowered to $4.50 at Morgan Stanleymarketbeat.com - March 28 at 10:17 AMPGRE vs. OHI: Which Stock Is the Better Value Option?zacks.com - March 27 at 12:41 PMParamount Signs 74,000 Square Foot Lease at 1301 Avenue of the Americasbusinesswire.com - March 18 at 8:00 AM7 REITs to Sell in March Before They Crash & Burninvestorplace.com - March 18 at 6:50 AMAre Investors Undervaluing Paramount Group (PGRE) Right Now?zacks.com - March 13 at 10:46 AMPGRE or OHI: Which Is the Better Value Stock Right Now?zacks.com - March 11 at 12:41 PMParamount Group May Surrender Two San Francisco Office Towers Amid Real Estate Challengeshoodline.com - March 6 at 6:21 PMParamount could return two downtown San Francisco office buildings to lenders as maturity dates loombizjournals.com - March 4 at 1:15 PMBuy Rating for Paramount Group: Strategic Growth in NYC’s Recovering Real Estate Marketmarkets.businessinsider.com - March 2 at 8:38 AMParamount Group: Blue Chip Tenants And Rock Bottom Valuationseekingalpha.com - March 1 at 3:34 PMIndependent Living Communities Near Paramount, CAhealth.usnews.com - February 29 at 1:37 PMIs Paramount Group (PGRE) Stock Undervalued Right Now?zacks.com - February 26 at 10:46 AMPGRE vs. CDP: Which Stock Is the Better Value Option?zacks.com - February 23 at 12:41 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come5 Top-Rated Dividend Stocks With Double-Digit UpsideMarch 25, 2024 11:19 AMView 5 Top-Rated Dividend Stocks With Double-Digit UpsideDocuSign and The Case for 66% Upside April 16, 2024 10:20 AMView DocuSign and The Case for 66% Upside All Headlines Company DescriptionsHealthpeak PropertiesNYSE:DOCHealthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.Keppel REITOTCMKTS:KREVFListed by way of an introduction on 28 April 2006, Keppel REIT is one of Asia's leading real estate investment trusts with a portfolio of prime commercial assets in Asia Pacific's key business districts. Keppel REIT's objective is to generate stable income and sustainable long-term total return for its Unitholders by owning and investing in a portfolio of quality income-producing commercial real estate and real estate-related assets in Asia Pacific. Keppel REIT has a portfolio value of over $9.0 billion, comprising properties in Singapore; the key Australian cities of Sydney, Melbourne and Perth; Seoul, South Korea; as well as Tokyo, Japan. Keppel REIT is managed by Keppel REIT Management Limited and sponsored by Keppel, a global asset manager and operator with strong expertise in sustainability-related solutions spanning the areas of infrastructure, real estate and connectivity.MFA FinancialNYSE:MFAMFA Financial, Inc., together with its subsidiaries, operates as a real estate investment trust in the United States. It invests in residential mortgage securities, including non-agency mortgage-backed securities, agency MBS, and credit risk transfer securities; residential whole loans, including purchased performing loans, purchased credit deteriorated, and non-performing loans; and mortgage servicing rights related assets. The company was incorporated in 1997 and is based in New York, New York.Corporate Office Properties TrustNYSE:OFCCOPT is a REIT that owns, manages, leases, develops and selectively acquires office and data center properties. The majority of its portfolio is in locations that support the United States Government and its contractors, most of whom are engaged in national security, defense and information technology (IT) related activities servicing what the Company believes are growing, durable, priority missions (Defense/IT Locations). The Company also owns a portfolio of office properties located in select urban submarkets in the Greater Washington, DC/Baltimore region with durable Class-A office fundamentals and characteristics (Regional Office Properties). As of June 30, 2023, the Company derived 90% of its core portfolio annualized rental revenue from Defense/IT Locations and 10% from its Regional Office Properties. As of the same date and including 24 properties owned through unconsolidated joint ventures, COPT's core portfolio of 192 properties encompassed 22.9 million square feet and was 95% leased.Paramount GroupNYSE:PGREParamount Group, Inc. ("Paramount" or the "Company") is a fully-integrated real estate investment trust that owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York and San Francisco. Paramount is focused on maximizing the value of its portfolio by leveraging the sought-after locations of its assets and its proven property management capabilities to attract and retain high-quality tenants. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.